NEWTOWN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies to target ...
High-titre convalescent plasma therapy given within a week of symptom onset reduced hospitalisation and death and was well tolerated in immunocompromised patients with mild COVID-19. This randomised ...
Larazotide, an oral drug, may effectively treat MIS-C by tightening the gut epithelial barrier, reducing systemic inflammation. The phase 2a trial showed faster resolution of GI symptoms and spike ...
Nov 23 (Reuters) - Merck & Co Inc (MRK.N), opens new tab has agreed to acquire drugmaker OncoImmune in a deal that will give it control of a drug that could help ease symptoms and reduce deaths in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback